News
Adjuvant capecitabine found disappointing in TNBC
SAN ANTONIO – A phase 3 trial was negative, showing that adding adjuvant capecitabine to surgery and chemotherapy does not improve survival in...
Video
No boost in OS with addition of capecitabine for early TNBC
SAN ANTONIO – Adding adjuvant capecitabine to surgery and standard chemotherapy did not improve disease-free or overall survival in women with...
News
Study reveals long-term survival in MM patients
A retrospective study suggests one in seven patients with newly diagnosed multiple myeloma (MM) who are eligible for transplant may live at least...
News
New data further support curability of myeloma
A study has found that a sizable share of transplant-eligible patients can expect to live as long as similar people in the general population.
News
Valve-in-valve TAVR benefits maintained at 3 years
SAN DIEGO – Improvements in heart failure functional class and quality of life after valve-in-valve TAVR are maintained out to at least 3 years....
News
Tumor burden in active surveillance for mRCC may inform treatment decisions
An Italian retrospective cohort study has found that tumor burden more consistently predicted survival than IMDC risk class and number of...
News
Transcatheter repair for tricuspid regurgitation holds up at 1 year
SAN DIEGO – The procedure reduced regurgitation to mild or moderate levels in nearly four-fifths of patients.
News
BIOFLOW V: Orsiro outperforms Xience stent
San Diego – Two-year results of the BIOFLOW V randomized head-to-head comparison show superiority was driven by a lower rate of target vessel–...
News
Striking racial/ethnic differences seen in RCC features
A retrospective cohort study of 294 patients with RCC finds that certain racial/ethnic minorities are younger at diagnosis and more often have...
News
KPNA2 is “novel prognostic factor” in RCC
Patients whose clear cell or papillary RCC expresses high levels of KPNA2, a transport carrier protein, have an elevated risk of death.
News
Time reveals benefit of CABG over PCI for left main disease
SAN DIEGO –
News
Obesity is linked to some RCC subtypes
A nested case-control study of nearly 5,000 individuals and a subsequent meta-analysis found that obese patients have elevated risks of clear cell...
News
Pazopanib is active against renal, other neoplasms of von Hippel-Lindau disease
In the single-arm, phase 2 trial, more than half of renal cell carcinomas responded to pazopanib, with a median reduction in tumor size of 40.5...
